for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Jazz Pharmaceuticals to acquire Celator Pharmaceuticals for $30.25 per share

May 31 (Reuters) - Celator Pharmaceuticals Inc

* Jazz Pharmaceuticals to acquire Celator for $30.25 per share

* Jazz Pharma expects to finance deal with a combination of cash on hand and borrowings under its senior secured credit facility

* Deal to add Vyxeos, to Jazz Pharmaceuticals’ portfolio

* Deal for about $1.5 billion

* Transaction expected to be accretive to non-gaap adjusted eps beginning in 2018 and beyond for Jazz Pharma

* Jazz Pharmaceuticals and Celator Pharmaceuticals announce agreement for Jazz Pharmaceuticals to acquire Celator for $30.25 per share Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up